Vaishali Parekh has recommended three stocks for today — Marksans Pharma, Deep Industries, and Alkem Laboratories.

Marksans Pharma Ltd (BOM:524404) reported a strong revenue growth of 20.8% year-on-year for Q2 FY25, driven by robust performance in the US, Australia, and New Zealand markets. The US market saw a ...

November 12, 2024 13:03 Stock market live today: Marksans Pharma Q2 net profit soars to ₹63.20 crore, shares rise 1.89% ...

Marksans Pharma added 2.70% to Rs 296.80 after the company reported 15.8% increase in consolidated net profit to Rs 96.72 crore on 20.83% rise in revenue from operations to Rs 641.92 crore in Q2 FY25 ...

Indiamart Intermeshs subsidiary, Tradezeal Online entered into share purchase agreement to disinvest a 26% stake in Shipway Technology by way of sale of 4,088 Compulsorily Convertible Preference ...

Ashoka Buildcon, Zydus Life, Nykaa and other key companies are set to release Q2 earnings today. Here’s the Bloomberg-tracked ...

Marksans Pharma, Medplus Health Services, Minda Corporation, Samvardhana Motherson International, Natco Pharma, Nucleus ...

In the coming truncated week, the markets are expected to consolidate further with stock-specific action due to global ...

Gain essential insights into the Marksans Pharma Ltd balance sheet with our detailed overview. Explore key financial metrics that highlight the company's financial position, including assets, ...

Ranked by Total comm. SF developed in Triangle from 2019-2023 Ranked by Local patents in fiscal year 2024 Ranked by No. of attorneys in NC Banc of California is proud to welcome Chris Hague as ...

Astellas Pharma (JP:4503) has released an update. Astellas Pharma Inc. reported a foreign exchange loss of ¥12.2 billion for the first half of FY2024, following fluctuations in currency rates ...

Strides Pharma reported Q2 FY25 net profit of ₹93 Crore, marking a recovery from a ₹131 Crore loss in the same quarter last year. Revenue for Q2 FY25 reached ₹1,201 Crore, reflecting a 20.2% ...